HR (95%CI) | P value | HR (95%CI) | P value | |
---|---|---|---|---|
TCGA | ||||
Age | 1.035 (1.019 ~ 1.051) | 1.82e-05* | 1.039 (1.018 ~ 1.061) | < 0.001* |
Gender-male | 0.872 (0.630 ~ 1.206) | 0.407 | ||
Pathological Stage | 1.703 (1.405 ~ 2.064) | 5.63e-08* | 1.236 (0.615 ~ 2.485) | 0.552 |
T stage | 1.702 (1.353 ~ 2.142) | 5.79e-06* | 1.173 (0.806 ~ 1.706) | 0.405 |
Histological grade | 2.915 (0.721 ~ 11.78) | 0.133 | ||
Lymphatic metastasis | 2.227 (1.625 ~ 3.051) | 6.29e-07* | 0.967 (0.385 ~ 2.427) | 0.942 |
Angiolymphatic invasion | 2.339 (1.601 ~ 3.416) | 1.1e-05* | 1.711 (1.054 ~ 2.777) | 0.030* |
Risk score | 3.584 (2.455 ~ 5.233) | 3.84e-11* | 2.521 (1.455 ~ 4.367) | < 0.001* |